Unknown PHASE2 INTERVENTIONAL 2-arm NCT02677259

Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles

Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: a Randomized, Controlled Study

Sponsor: One Fertility

Conditions IVF

Interventions 17-beta estradiol Micronized progesterone

Updated 7 times since 2017 Last updated: Feb 9, 2016 Started: May 31, 2016 Primary completion: Jun 30, 2018 Completion: Jun 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02677259, this PHASE2 trial focuses on IVF and remains ongoing. Sponsored by One Fertility, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jul 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Jul 2018 [monthly]

Not Yet Recruiting PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE2
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting PHASE2

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

One Fertility

Data source: One Fertility

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.